You are now leaving the Kedrion website. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
  • Slide Image

    KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • Slide Image

    KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • Slide Image

    KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  1. 1
  2. 2
  3. 3

News

CORPORATE

Kedrion announces the appointment of a new CEO

Val Romberg from the USA, one of the most esteemed managers in the industry

read more 

CORPORATE

KEDPLASMA GmbH changes its name to Kedrion Biopharma GmbH

Further step towards an even stronger focus on patients in Europe

read more 

CORPORATE

COVID-19. Kedrion partners with Columbia University Irving MC

Kedrion and Columbia University release video statements

read more 

2019
ANNUAL REPORT

PHARMACOVIGILANCE

MEDICAL & SCIENTIFIC INFORMATION

Kedrion hilite image